Features, pricing, ratings, and pros and cons, compared head to head.
Axonius Unified Device Observability is a commercial medical device security tool by Axonius. SAM rAPId is a commercial ot asset discovery tool by SAM Seamless Network. Compare features, ratings, integrations, and community reviews side by side to find the best medical device security fit for your security stack. Independent and vendor-neutral: our scores and rankings are earned, never bought — sponsored placement is always labeled.
Healthcare IT and clinical engineering teams managing sprawling medical device fleets will get the most from Axonius Unified Device Observability because it actually classifies devices by protocol and clinical function rather than treating them as generic assets. The platform ingests from CMMS, EHR, RTLS, and network telemetry simultaneously, giving you a single authoritative record of 150+ device attributes that most asset tools simply cannot correlate. Skip this if your priority is incident response automation; Axonius prioritizes continuous monitoring and asset classification over playbook execution, making it stronger on the ID and DE functions than PR.IR. Startups and mid-market ops teams struggling to inventory IoT and OT devices will find SAM rAPId's fingerprinting database of 500M+ devices far more useful than generic asset scanners that return incomplete or misclassified results. The API-first model means you integrate it directly into your existing workflows instead of running another scanning tool, and batch identification lets you process thousands of devices without manual effort. Skip this if your network is purely IT infrastructure with standard servers and workstations; you'll get better value from cheaper CMDB tools that don't need the fingerprinting layer SAM rAPId is built around.
Based on our analysis of NIST CSF 2.0 coverage, core features, integrations, company size fit, here is our conclusion:
Axonius Unified Device Observability
Healthcare IT and clinical engineering teams managing sprawling medical device fleets will get the most from Axonius Unified Device Observability because it actually classifies devices by protocol and clinical function rather than treating them as generic assets. The platform ingests from CMMS, EHR, RTLS, and network telemetry simultaneously, giving you a single authoritative record of 150+ device attributes that most asset tools simply cannot correlate. Skip this if your priority is incident response automation; Axonius prioritizes continuous monitoring and asset classification over playbook execution, making it stronger on the ID and DE functions than PR.IR.
Startups and mid-market ops teams struggling to inventory IoT and OT devices will find SAM rAPId's fingerprinting database of 500M+ devices far more useful than generic asset scanners that return incomplete or misclassified results. The API-first model means you integrate it directly into your existing workflows instead of running another scanning tool, and batch identification lets you process thousands of devices without manual effort. Skip this if your network is purely IT infrastructure with standard servers and workstations; you'll get better value from cheaper CMDB tools that don't need the fingerprinting layer SAM rAPId is built around.
Asset visibility & risk mgmt platform for healthcare medical & IT devices
API for device identification & CVE enrichment using device fingerprinting.
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing Axonius Unified Device Observability vs SAM rAPId for your medical device security needs.
Axonius Unified Device Observability: Asset visibility & risk mgmt platform for healthcare medical & IT devices. built by Axonius. Core capabilities include Medical device discovery and classification with 150+ attributes per asset, Support for medical protocols including HL7, DICOM, RTLS, and MDS2, Fleet-level risk scoring with FDA and MDS2 data integration..
SAM rAPId: API for device identification & CVE enrichment using device fingerprinting. built by SAM Seamless Network. Core capabilities include Device identification returning manufacturer, class, model, sub-model, product name, and OS, Support for multiple types of network and device data inputs, Individual and batch device identification..
Both serve the Medical Device Security market but differ in approach, feature depth, and target audience.
Axonius Unified Device Observability differentiates with Medical device discovery and classification with 150+ attributes per asset, Support for medical protocols including HL7, DICOM, RTLS, and MDS2, Fleet-level risk scoring with FDA and MDS2 data integration. SAM rAPId differentiates with Device identification returning manufacturer, class, model, sub-model, product name, and OS, Support for multiple types of network and device data inputs, Individual and batch device identification.
Axonius Unified Device Observability is developed by Axonius. SAM rAPId is developed by SAM Seamless Network. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.
Axonius Unified Device Observability and SAM rAPId serve similar Medical Device Security use cases. Review the feature comparison above to determine which fits your requirements.
Get strategic cybersecurity insights in your inbox